We only have this paper's title and publication details.
Read it at the sourceCombinatorial treatments with navitoclax and survivin inhibitors significantly inhibit tumor growth in ovarian cancer, suggesting enhanced therapeutic strategies.
Combinatorial screens of active compounds
No takes yet. Share an insight, caveat, or question.
Kenny et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: